Mild obstructive sleep apnea (OSA) is often underdiagnosed but contributes to treatment-resistant hypertension through oxygen deprivation and activation of the renin-angiotensin-aldosterone system. This evidence concerns the gene REN and obstructive sleep apnea syndrome.